I joined NDORMS in 2017 as a member of the Musculoskeletal Pharmacoepidemiology group in order to enter a DPhil programme at the beginning of the academic year 2017/2018. My research is going to be focused on method development for the risk-benefit evaluation of surgical procedures.
Previously I worked at the Department of Clinical Epidemiology of the Aarhus University, collaborated with the Department of Medical Informatics of the Erasmus Medical Center and studied medicine and mathematics in Budapest.
Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.
Stidsen JV. et al, (2018), Diabetes/metabolism research and reviews, 34
Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile.
Christensen DH. et al, (2018), BMJ open, 8
Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
Gedebjerg A. et al, (2018), Journal of diabetes and its complications, 32, 34 - 40
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Study Cohort: Presentation of 5,870 Patients with New Type 2 Diabetes Enrolled from 2010 Through 2014
Christensen DH. et al, (2016), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 394 - 395
The Impact Of Risk Minimisation Measures On The Incidence And Prevalence Of Use Of Strontium Ranelate At The Population Level: Preliminary Results Of A Multi-National Cohort Study Including 5 European Countries
Berencsi K. et al, (2016), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 7 - 8